![Paul Townsend](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul Townsend
Plus aucun poste en cours
Profil
Paul Townsend is the founder of Karus Therapeutics Ltd.
which was founded in 2005.
He also worked as a Non-Executive Director at Aptamer Group Plc.
Mr. Townsend received an undergraduate degree from York University.
Anciens postes connus de Paul Townsend
Sociétés | Poste | Fin |
---|---|---|
APTAMER GROUP PLC | Directeur/Membre du Conseil | - |
Karus Therapeutics Ltd.
![]() Karus Therapeutics Ltd. BiotechnologyHealth Technology Karus Therapeutics Ltd. provides therapies for treatment of cancer and inflammatory diseases. It offers HDAC6 and PI3K inhibitors for the treatment of cancer. The firm’s products in pipeline include KA-2237, KAR4000 Series and KAR3000 Series for the treatment of chronic inflammation, haematological malignancies, and solid tumours. The company was founded in July 2005 by Arasu Ganesan, Graham Keith Packham and Paul Townsend and is headquartered in Abingdon, the United Kingdom. | Fondateur | - |
Formation de Paul Townsend
York University | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
Sociétés cotées | 1 |
---|---|
APTAMER GROUP PLC | Health Technology |
Entreprise privées | 1 |
---|---|
Karus Therapeutics Ltd.
![]() Karus Therapeutics Ltd. BiotechnologyHealth Technology Karus Therapeutics Ltd. provides therapies for treatment of cancer and inflammatory diseases. It offers HDAC6 and PI3K inhibitors for the treatment of cancer. The firm’s products in pipeline include KA-2237, KAR4000 Series and KAR3000 Series for the treatment of chronic inflammation, haematological malignancies, and solid tumours. The company was founded in July 2005 by Arasu Ganesan, Graham Keith Packham and Paul Townsend and is headquartered in Abingdon, the United Kingdom. | Health Technology |